Use of Repris Needle in Bladder Injection

Status Recruiting

Clinical Trial Summary

Treatment of overactive bladder (OAB) has been treated successfully by the injection of Botox. The Repris injection needle has a deflection that may assist in injection difficult to reach with standard straight needles. This study will assess the success, safety and patient tolerance of this new injection needle.

Clinical Trial Description

This is a prospective, multicenter, single arm study of the Repris injection needle to administer Botox to the bladder wall in patients with an overactive bladder. Following advancement of a cystoscope to the patient's bladder, the Repris needle will be advanced to the area of interest and into the bladder wall in order to administer the recommended volume of Botox. After injection, the needle will be removed and the procedure will be concluded. The patient will be asked to rank her tolerance of the procedure and level of discomfort using a standardized pain scale before being released. Five days after the procedure the patient will be contacted by telephone to determine whether any adverse events had occurred since release. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04982120
Study type	Interventional
Source	Uro-1 Medical
Contact	Thomas Lawson, PhD
Phone	5102061794
Email	drthomlawson@gmail.com
Status	Recruiting
Phase	N/A
Start date	October 15, 2018
Completion date	July 14, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02540707` - Comparisons of the Effects of Solifenacin Versus Mirabegron on Autonomic System, Arterial Stiffness and Psychosomatic Distress and Clinical Outcomes	Phase 4
Not yet recruiting	`NCT05977634` - Transcutaneous Tibial Nerve Stimulation for Idiopathic Overactive Bladder	N/A
Not yet recruiting	`NCT06438861` - Role of Combination Therapy in Women With Refractory Overactive Bladder	N/A
Completed	`NCT01114412` - Basic Sensations Coming From the Bladder
Recruiting	`NCT06045728` - Telerehabilitation for Overactive Bladder Syndrome in Obese Women	N/A
Recruiting	`NCT03952299` - Oxybutynin for Post-surgical Bladder Pain and Urgency	Phase 3
Active, not recruiting	`NCT03758235` - Overactive Bladder Syndrome: Incobotulinumtoxin Versus Onabotulinumtoxin	Phase 3
Completed	`NCT01912885` - Comparison of Posterior Tibial Nerve Electrical Stimulation Protocols for Overactive Bladder Syndrome	N/A
Completed	`NCT04300400` - Treatment of the Overactive Bladder Syndrome: A Delphi Study
Completed	`NCT06123364` - Extracorporeal Magnetic Innervation in Combination With Mirabegron in the Treatment of Overactive Bladder	N/A
Recruiting	`NCT06088394` - Effect of Acupuncture Augmented With Pelvic Floor Exercises on Overactive Bladder	N/A
Recruiting	`NCT05221021` - Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder Syndrome	Phase 4
Terminated	`NCT04256876` - TTNS Versus Sham Therapy for Children With iOAB (TaPaS Part I)	N/A
Not yet recruiting	`NCT03331081` - Effects of Bladder Training and Pelvic Floor Muscle Training on the Symptomatology of Overactive Bladder Syndrome	N/A
Recruiting	`NCT04873037` - BTL Emsella Chair Versus Sham for the Treatment of Overactive Bladder	N/A
Completed	`NCT02024945` - Efficacy, Tolerability and Impact on Quality of Life of Propiverine in Patients With Overactive Bladder Syndrome	Phase 4
Completed	`NCT00546637` - Fesoterodine "add-on" Male Overactive Bladder Study	Phase 3
Not yet recruiting	`NCT06143397` - Effect of TTNS and PNS on Neurogenic Overactive Bladder Symptoms in Female Patients With Multiple Sclerosis.	N/A
Recruiting	`NCT03044912` - Therapeutic Efficacy and Safety of Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan	Phase 3
Recruiting	`NCT03817203` - Effects of Kinesio Taping Application in Women With Overactive Bladder	N/A